Philadelphia, PA – October 31, 2024 – The Penn Center for Innovation is deeply saddened by the passing of Eric Corkhill, who served as Chairman and CEO of Neuralert Technologies, a Penn spin-out company. Eric joined Neuralert in June 2020, working closely with co-founders Steven Messe (Professor of Neurology, Penn Medicine), James Weimer (Assistant Professor of Computer Science, Vanderbilt University), and CTO Det Ansinn, to achieve their objective of transforming the care of patients with stroke.
Eric was an inspiring leader, and an exceptionally kind and generous person, who profoundly shaped Neuralert’s journey. Under Eric’s leadership, Neuralert made significant strides in their plans to develop the first lightweight, non-invasive device capable of providing continuous stroke monitoring and automatic alerts for timely treatments and improved outcomes. Driven by his commitment to save lives and prevent disability after stroke, Eric led the company to milestone achievements including an FDA Breakthrough Device designation in 2021 and Time Magazine’s recognition of Neuralert’s device as one of the best inventions of 2022. PCI Ventures celebrated Eric as CEO of the Year in 2023 for his unwavering dedication and remarkable accomplishments.
Eric’s contributions to Neuralert will endure as part of his legacy. Under the leadership of CEO, Det Ansinn, the Neuralert team is committed to fulfilling his vision for the company.
The Penn Center for Innovation extends its deepest condolences to Eric’s family, friends, and colleagues. Eric will be greatly missed.
For more information on Eric’s life and accomplishments, please refer to his obituary.